Welcome to The Pearl Log — where post-shift wisdom surfaces, one shiny clinical take at a time. Some pearls are fresh, some are rough, all are found under pressure.
Find a Pearl
Atrial Fibrillation Guideline Check-In
Despite differences across AF guidelines, ED management converges on three principles: initiate DOACs when stroke risk warrants, cardiovert fewer patients but with more attention to duration and risk, and ensure early referral for rhythm-control discussion in newly diagnosed AF. The ED role is less about choosing the “right” guideline and more about safe initiation, thoughtful restraint, and reliable follow-up.
Apixaban or Rivaroxaban for VTE?
Apixaban and rivaroxaban both block factor Xa, but real-world data give apixaban the edge. Across AFib and VTE cohorts, apixaban consistently shows lower rates of major and GI bleeding with similar efficacy. Rivaroxaban’s once-daily dosing helps adherence, but that convenience trades off a bit of safety margin. Until head-to-head RCTs land, patients will probably fare better on apixaban.